Xebio Holdings Co. Ltd. | Income Statement
Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
204,779
210,672
221,391
223,353
234,595
231,629
Cost of Goods Sold (COGS) incl. D&A
128,729
135,320
141,021
139,298
146,020
147,375
Gross Income
76,050
75,352
80,370
84,055
88,575
84,254
SG&A Expense
63,755
69,698
74,200
76,626
77,883
78,508
EBIT
12,295
5,654
-
7,429
10,692
5,746
Unusual Expense
995
2,521
1,611
1,098
2,416
2,224
Non Operating Income/Expense
571
662
97
143
496
777
Interest Expense
23
23
51
10
5
12
Pretax Income
11,976
3,873
4,701
6,575
8,858
4,351
Income Tax
5,603
1,948
2,590
3,591
4,602
2,458
Consolidated Net Income
6,373
1,925
2,111
2,983
4,256
1,892
Net Income
6,618
2,084
2,119
2,991
4,249
1,885
Net Income After Extraordinaries
6,618
2,084
2,119
2,991
4,249
1,885
Net Income Available to Common
6,618
2,084
2,120
2,991
4,249
1,884
EPS (Basic)
146.92
46.24
46.95
66.88
95.07
42.40
Basic Shares Outstanding
45
45
45
45
45
44
EPS (Diluted)
146.68
46.18
46.84
66.77
94.79
42.30
Diluted Shares Outstanding
45
45
45
45
45
45
EBITDA
18,790
12,219
12,474
13,562
15,958
10,279
Non-Operating Interest Income
128
101
100
113
94
66
Minority Interest Expense
245
159
8
8
7
7
About Xebio Holdings Co.
View Profile
